 |
David M Brown; David S Boyer; Diana V Do; Charles C Wykoff; Taiji Sakamoto; Peter Win; Sunir Joshi; Hani Salehi-Had; Seres András; Alyson J Berliner; Sergio Leal; Robert Vitti; Karen W Chu; Kimberly Reed; Rohini Rao; Yenchieh Cheng; Wei Sun; Delia Voronca; Rafia Bhore; Ursula Schmidt-Ott; Thomas Schmelter; Andrea Schulze; Xin Zhang; Boaz Hirshberg; George D Yancopoulos; Sobha Sivaprasad; Kollaborációs szervezet: PHOTON Investigators; Bátor György; Kerényi Ágnes; Kiss Katalin; Milibák Tibor; Papp András; Seres András; Tóth-Molnár Edit; Vajas Attila; Varsányi Balázs:
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON) : 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial.
LANCET, 403 (10432).
pp. 1153-1163.
ISSN 0140-6736
(2024)
Shimura Masahiko; Kitano Shigehiko; Ogata Nahoko; Mitamura Yoshinori; Oh Hideyasu; Kollaborációs szervezet: YOSEMITE and RHINE Investigators; Bátor György; Seres András; Szalczer Lajos; Tóth-Molnár Edit; Vajas Attila; Varsány Balázs; Kerény Ágnes; Papp András; Szecskó Tímea; Vogt Gábor:
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1‑year results from the Japan subgroup of the phase 3 YOSEMITE trial.
JAPANESE JOURNAL OF OPHTHALMOLOGY, 67 (3).
pp. 264-279.
ISSN 0021-5155
(2023)
![[Fel]](/style/images/multi_up.png)
Vissza
